Trademark: 86836612
Word
SL SNOTRA LABORATORIES
Status
Dead
Status Code
606
Status Date
Monday, January 29, 2018
Serial Number
86836612
Mark Type
3000
Filing Date
Wednesday, December 2, 2015
Published for Opposition
Tuesday, November 1, 2016
Abandoned Date
Monday, January 29, 2018

Trademark Owner History
SNOTRA LABORATORIES, INC. - Owner At Publication

Classifications
35 Project management services for others for business purposes in the field of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; providing project management services for others for business purposes related to the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; business consultation in the field of healthcare, namely, providing independent consultative review of clinical trials, peri-approval studies, post-approval studies, observational studies, post-approval surveys and clinical patient registries, post-approval marketing studies, quality improvement, and patient support programs in the healthcare, biopharmaceutical, and medical device and diagnostic industries all excluding the provision of medical services and medical treatment services
42 Scientific research and development; conducting research and development services in the field of pharmaceuticals and medical devices; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; conducting clinical trials of pharmaceuticals and medical devices; scientific research services, namely, tracking, analyzing, forecasting, and reporting data in the field of clinical trials of pharmaceuticals and medical devices; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others; medical and scientific research in the nature of conducting peri-approval studies and post-approval studies evaluating the safety, effectiveness, value, risk, and quality of healthcare products, therapies an medical services; providing information relating to the development and validation of drugs, pharmaceutical products, medical products, medical devices and biologics; medical and scientific research featuring peri-approval studies and post-approval studies for evaluating the safety, effectiveness, value, risk, and quality of healthcare products, therapies, and medical services
44 Medical services in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices. Providing health, medical, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, evaluating disease management and treatment protocols and patient outcome analysis services
Color is not claimed as a feature of the mark.
"LABORATORIES"
The mark consists of a stylized "S" and a stylized "L" forming a robotic arm grip to the left of the words SNOTRA LABORATORIES and a diacritical mark over the "o" in SNOTRA.

Trademark Events
Jan 29, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jan 29, 2018
Abandonment - No Use Statement Filed
Jun 24, 2017
Notice Of Approval Of Extension Request E-Mailed
Jun 22, 2017
Extension 1 Granted
Jun 22, 2017
Extension 1 Filed
Jun 22, 2017
Teas Extension Received
Dec 27, 2016
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2016
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2016
Published For Opposition
Oct 12, 2016
Notification Of Notice Of Publication E-Mailed
Sep 23, 2016
Approved For Pub - Principal Register
Sep 22, 2016
Teas/Email Correspondence Entered
Sep 22, 2016
Correspondence Received In Law Office
Sep 22, 2016
Teas Response To Office Action Received
Mar 24, 2016
Notification Of Non-Final Action E-Mailed
Mar 24, 2016
Non-Final Action E-Mailed
Mar 24, 2016
Non-Final Action Written
Mar 21, 2016
Assigned To Examiner
Dec 9, 2015
Notice Of Design Search Code E-Mailed
Dec 8, 2015
New Application Office Supplied Data Entered In Tram
Dec 5, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24